Following the introduction of a package of measures providing additional support for businesses many SME companies will be looking at whether they need to, or are able to, access the recently introduced Corona virus Business Interruption Loan Scheme (CBILS). However the complex rules around which R&D tax relief an SME is able to claim under means that companies need to understand the potential adverse effect taking such a loan may have on their R&D claim and future cash flow.
Kingly Brookes has set the issue in more detail on its website and you can read about it by following this link.
If you would like to know more about this, or discuss its application to your company, then please contact John Moore on 0207 292 8850 or at john.moore@kinglybrookesllp.co.uk